GO:0072663 establishment of protein localization to peroxisome: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0072663 describes the directed movement of a protein to a specific location inside a peroxisome, a process required for peroxisomal metabolic and quality-control functions.
• Protein delivery to peroxisomes depends on folded-protein translocation machinery and membrane-associated import receptors, distinguishing it from ER-based translocation.
• Peroxisomal protein localization intersects with mitochondrial quality control, lipid remodeling, and organelle crosstalk pathways [1,3,6].
• Dysregulation of peroxisomal protein targeting is linked to metabolic stress, cancer cell survival, and organelle dysfunction [1,6].
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential to test causality of peroxisome-targeting genes.
• Multicolor organelle markers and co-localization imaging enable direct visualization of peroxisomal protein localization in vivo.
Description
GO:0072663, establishment of protein localization to peroxisome, is a biological process term that captures the directed movement of a protein to a specific location within a peroxisome. Peroxisomes are single-membrane organelles that house oxidative reactions, lipid metabolism, and reactive oxygen species handling, and their functions depend on the correct delivery of both matrix and membrane proteins. Because peroxisomes lack their own genome for most protein-coding capacity, the establishment of protein localization to peroxisomes is a fundamental cell biological problem that determines organelle identity and metabolic output. Researchers study this term to understand how folded proteins cross or insert into the peroxisomal membrane, how import receptors cycle, and how defects in these steps contribute to disease. The process is also relevant to organelle quality control, because peroxisomal proteins must be correctly localized for peroxisomes to participate in mitochondrial and lipid homeostasis [1,6]. In this article, we integrate the QuickGO definition with verified PubMed literature to provide a research-grade overview of GO:0072663, its genes, regulation, disease links, and experimental models.
establishment of protein localization to peroxisome At A Glance
| GO ID | GO:0072663 |
|---|---|
| GO term | establishment of protein localization to peroxisome |
| Ontology | biological_process |
| Synonym | establishment of protein localisation to peroxisome |
| Definition | The directed movement of a protein to a specific location in a peroxisome. |
| Major function | Targets and delivers proteins to peroxisomal compartments, enabling peroxisomal metabolism and organelle identity. |
| Related cellular context | Peroxisomal membrane and matrix; overlaps with mitochondrial quality control and lipid metabolism pathways [1,3,6]. |
| Experimental readouts | Co-localization imaging with organelle markers, proteomics, and CRISPR-based perturbation [4,7]. |
What Is GO:0072663?
In our own words, GO:0072663 describes the directed movement of a protein to a specific location in a peroxisome. This includes the recognition, targeting, membrane translocation or insertion, and final deposition of proteins into peroxisomal compartments such as the matrix or membrane. The term is a biological process and is synonymous with establishment of protein localisation to peroxisome. It is distinct from broader protein transport terms because it specifies the peroxisome as the destination and emphasizes the establishment of localization rather than only the transport reaction.
Why Is establishment of protein localization to peroxisome Important in Cell Biology?
Establishment of protein localization to peroxisome is important because peroxisomes cannot fulfill their metabolic and signaling roles unless the correct proteins reach the correct peroxisomal location. Defects in peroxisomal protein targeting impair lipid metabolism, redox balance, and organelle crosstalk, which are processes linked to cancer cell survival and metabolic stress responses [1,6]. Understanding GO:0072663 therefore provides mechanistic insight into organelle biogenesis, quality control, and disease-associated pathways, and it offers a framework for designing CRISPR models that test gene function in peroxisomal biology.
• Defines how folded proteins are delivered to peroxisomes, a non-ER translocation route.
• Supports peroxisomal metabolic functions, including lipid and reactive oxygen species handling.
• Connects peroxisomal protein targeting to mitochondrial quality control and mitophagy pathways [1,6].
• Provides a mechanistic basis for understanding organelle crosstalk in cancer cell survival.
• Enables co-localization studies using multicolor organelle markers in plant and other systems.
• Helps interpret proteomic and imaging data on peroxisomal composition.
• Guides CRISPR knockout and knock-in strategies for peroxisome-related genes.
• Links peroxisomal protein localization to lipid droplet and phospholipid remodeling biology [3,8].
• Offers a framework for studying disease-associated mutations in targeting machinery.
• Supports development of organelle-specific reporters and localization assays.
What Happens During establishment of protein localization to peroxisome?
Recognition and targeting of peroxisomal proteins
In simple terms: The cell first identifies which proteins belong in the peroxisome.
The establishment of protein localization to peroxisome begins with recognition of targeting signals that direct proteins toward the peroxisome rather than other organelles. This step is critical because peroxisomal proteins must be distinguished from mitochondrial, ER, and cytosolic proteins, and the targeting information is decoded by cytosolic and membrane-associated factors. The process is part of a broader membrane translocation problem for folded proteins, which requires dedicated machinery rather than the unfolded-protein channels used in the ER.
Membrane translocation and insertion
In simple terms: Proteins cross or insert into the peroxisomal membrane.
After targeting, proteins are translocated across or inserted into the peroxisomal membrane, a step that depends on membrane-associated import components and folded-protein translocation mechanisms. This step establishes the protein at a specific peroxisomal location, which is the defining outcome of GO:0072663. The membrane translocation of folded proteins is mechanistically distinct from ER translocation and is central to peroxisomal biogenesis.
Delivery to peroxisomal matrix or membrane subcompartments
In simple terms: Proteins are placed in the correct peroxisomal compartment.
Once proteins reach the peroxisome, they must be deposited in the correct subcompartment, such as the matrix or membrane, to support peroxisomal metabolism. This final localization step ensures that enzymes and structural proteins are positioned to carry out oxidative and lipid metabolic reactions. Correct subcompartment localization is also necessary for peroxisomes to participate in organelle quality control and crosstalk with mitochondria [1,6].
Quality control and recycling of targeting factors
In simple terms: The cell checks the delivery and reuses the transport machinery.
Establishment of protein localization to peroxisome is coupled to quality control and recycling of targeting factors so that import can continue. This step prevents accumulation of mislocalized proteins and maintains peroxisomal function under metabolic stress. Dysregulation of these quality-control steps can influence cell survival pathways, including those linked to mitochondrial quality control [1,6].
Key Genes Involved in GO:0072663 establishment of protein localization to peroxisome
The following genes and proteins are experimentally and conceptually linked to peroxisomal protein localization and related organelle quality-control pathways, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CLU | Clusterin involved in mitophagy and mitochondrial biogenesis control | Links organelle quality control to cancer cell survival |
| PPARGC1A | PGC1alpha regulates mitochondrial biogenesis and mitophagy | Coordinates organelle quality control with metabolic stress |
| CREG1 | Modulates mitophagy and skeletal muscle endurance response | Connects organelle quality control to exercise adaptation |
| GSTK1 | Supports mitochondrial quality control via PGAM5/DRP1 complex | Links metabolic control to organelle dynamics |
| PGAM5 | Part of mitochondrial quality control complex | Implicated in organelle quality control signaling |
| DRP1 | Mitochondrial fission regulator | Connects organelle dynamics to quality control |
| PLA2G2F | Phospholipid remodeling and ferroptosis suppression | Links lipid remodeling to organelle membrane biology |
| FNDC5 | Irisin precursor linked to PGC-1alpha signaling | Connects exercise and organelle signaling |
| BDNF | Neurotrophic signaling factor | Linked to PGC-1alpha/Irisin pathway in ischemia models |
| Peroxisomal import receptors | Recognize and deliver peroxisomal proteins | Core machinery for GO:0072663 |
| Peroxisomal membrane proteins | Form the peroxisomal membrane and import platform | Essential for protein localization to peroxisome |
| Peroxisomal matrix enzymes | Carry out peroxisomal metabolic reactions | Depend on correct localization for function |
| Organelle marker proteins | Enable co-localization imaging of peroxisomes | Support visualization of protein localization |
| Lipid droplet proteins | Participate in lipid storage and organelle crosstalk | Relevant to peroxisome-lipid interactions |
| Ferroptosis regulators | Control lipid peroxidation and cell death | Link peroxisomal lipid biology to stress responses |
| Mitophagy regulators | Control mitochondrial removal | Connect peroxisomal biology to organelle quality control [1,2] |
| Metabolic stress sensors | Respond to nutrient and energy status | Modulate organelle quality control pathways |
How Is establishment of protein localization to peroxisome Regulated?
The establishment of protein localization to peroxisome is regulated at multiple levels, including the availability of targeting signals, the activity of membrane translocation machinery, and the recycling of import factors. Organelle quality-control pathways, such as mitophagy and mitochondrial biogenesis, can influence the broader cellular context in which peroxisomal protein localization occurs [1,2]. Metabolic stress and lipid remodeling pathways also intersect with peroxisomal function, as shown by studies on phospholipid remodeling and ferroptosis suppression. In addition, mitochondrial quality control complexes involving PGAM5 and DRP1 can affect organelle dynamics that are relevant to peroxisomal protein targeting.
establishment of protein localization to peroxisome and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CLU | Oral cancer cell survival and mitophagy | Knockout and overexpression in oral cancer cell lines |
| PPARGC1A | Mitochondrial biogenesis and metabolic stress | Knock-in reporter and knockout models |
| GSTK1 | Hepatocellular carcinoma and mitochondrial quality control | Knockout and point-mutation models |
| PLA2G2F | Ferroptosis and phospholipid remodeling | Overexpression and knockout models |
| CREG1 | Skeletal muscle endurance and mitophagy | Knockout and overexpression models |
Cancer cell survival and metabolic stress
Peroxisomal protein localization supports metabolic and redox functions that cancer cells rely on for survival under stress. CLU and PPARGC1A/PGC1alpha coordinately control mitophagy and mitochondrial biogenesis, linking organelle quality control to oral cancer cell survival. GSTK1 suppresses hepatocellular carcinoma aggravation via L-carnitine metabolism and PGAM5/DRP1-mediated mitochondrial quality control, indicating that organelle quality-control pathways intersect with peroxisomal biology.
Organelle dysfunction and neurodegeneration
Defects in protein targeting to peroxisomes can impair organelle function and contribute to cellular stress, which is relevant to neurodegenerative and ischemic conditions. PGC-1alpha/Irisin/BDNF signaling is altered in focal cerebral ischemic/reperfusion injury, highlighting the importance of organelle quality control in neural tissue. Although direct peroxisomal protein localization defects are not fully characterized in these models, the shared organelle quality-control pathways suggest a mechanistic link [1,5].
Lipid metabolism and ferroptosis
Peroxisomes participate in lipid metabolism, and phospholipid remodeling by PLA2G2F suppresses ferroptosis, connecting peroxisomal lipid biology to cell death regulation. Lipid droplet biogenesis is also functionally linked to organelle crosstalk and lipid storage, which can influence peroxisomal protein localization indirectly. These findings suggest that peroxisomal protein targeting is part of a broader lipid homeostasis network relevant to disease [3,8].
From establishment of protein localization to peroxisome-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for peroxisomal protein localization? | CRISPR knockout cell model |
| Does a disease-associated mutation alter peroxisomal targeting? | Point-mutation knock-in model |
| Where does a protein localize within the peroxisome? | Tagged knock-in with fluorescent reporter |
| Does overexpression of a gene enhance peroxisomal localization? | Overexpression cell model |
| Which genes regulate peroxisomal protein delivery under stress? | CRISPR library screening |
| How does organelle crosstalk affect peroxisomal targeting? | Co-culture and imaging with organelle markers |
How to Study the establishment of protein localization to peroxisome Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorescence co-localization imaging | Overlap between protein and peroxisomal markers | Validate peroxisomal localization |
| Proteomics of organelle fractions | Protein composition of peroxisomes | Identify localization-dependent proteins |
| CRISPR knockout | Loss-of-function effects on localization | Test gene requirement for GO:0072663 |
| Point-mutation knock-in | Effect of specific mutations on targeting | Model disease-associated variants |
| Tagged knock-in | Real-time localization of endogenous protein | Track peroxisomal delivery |
| Overexpression | Gain-of-function effects on localization | Test sufficiency of targeting signals |
| CRISPR library screening | Genome-wide regulators of localization | Discover novel peroxisomal targeting genes |
| Mitophagy assays | Organelle quality-control activity | Assess crosstalk with peroxisomal biology [1,2] |
Imaging and co-localization
Multicolored in vivo organelle markers enable co-localization studies to determine whether a protein of interest reaches the peroxisome. These imaging approaches are essential for validating the establishment of protein localization to peroxisome and for distinguishing peroxisomal from mitochondrial or ER signals.
Proteomics and organelle profiling
Proteomic profiling of peroxisomal fractions can identify proteins whose localization depends on specific targeting machinery. Such datasets help define the protein composition of peroxisomes and reveal candidate regulators of GO:0072663.
CRISPR perturbation and functional genomics
CRISPR knockout, point-mutation, and knock-in models allow causal testing of genes implicated in peroxisomal protein localization. Library screening can identify novel regulators of peroxisomal targeting under metabolic stress.
Organelle quality-control assays
Mitophagy and mitochondrial quality-control assays provide context for how peroxisomal protein localization intersects with broader organelle homeostasis [1,2,6]. These assays can be combined with peroxisomal markers to assess crosstalk [1,6].
How CRISPR Can Be Used to Study GO:0072663 establishment of protein localization to peroxisome
Knockout
CRISPR knockout models are used to delete candidate genes and determine whether they are required for establishment of protein localization to peroxisome. Loss-of-function phenotypes can be assessed by imaging peroxisomal markers and by proteomic profiling of organelle fractions [4,7].
Point Mutation
Point-mutation knock-in models introduce specific disease-associated or mechanistic mutations to test how single amino acid changes affect peroxisomal protein targeting. These models are valuable for dissecting targeting signal recognition and membrane translocation steps.
Knock-in
Tagged knock-in models express endogenous proteins with fluorescent or affinity tags, enabling real-time tracking of protein localization to peroxisomes. This approach preserves native regulation and is ideal for co-localization studies with organelle markers.
Overexpression
Overexpression models test whether increased levels of a gene product enhance or disrupt peroxisomal protein localization. They are useful for gain-of-function studies and for validating sufficiency of targeting signals.
How EDITGENE Supports establishment of protein localization to peroxisome Research
Researchers studying establishment of protein localization to peroxisome-related genes often need to determine whether a candidate gene is causally involved in peroxisomal targeting, how specific mutations affect localization, and whether overexpression or loss of function alters organelle function. EDITGENE provides CRISPR-based cell models and screening services that address these questions with publication-ready rigor.
Contact EDITGENE today to design your custom CRISPR model for establishment of protein localization to peroxisome research.
Frequently Asked Questions About establishment of protein localization to peroxisome
What is GO:0072663 establishment of protein localization to peroxisome?
GO:0072663 is a biological process term describing the directed movement of a protein to a specific location in a peroxisome.
What genes are involved in establishment of protein localization to peroxisome?
Genes involved include peroxisomal import receptors, peroxisomal membrane proteins, and related organelle quality-control genes such as CLU, PPARGC1A, GSTK1, and PLA2G2F [1,6,7,8].
Why is protein localization to peroxisomes important?
It ensures peroxisomes receive the enzymes and structural proteins needed for lipid metabolism, redox balance, and organelle crosstalk [3,7].
How do proteins get into peroxisomes?
Proteins are recognized by targeting signals and translocated across or inserted into the peroxisomal membrane via folded-protein translocation machinery.
What diseases are linked to peroxisomal protein localization?
Dysregulation is linked to cancer cell survival, metabolic stress, and organelle dysfunction in ischemic and neurodegenerative contexts [1,5,6].
What methods study peroxisomal protein localization?
Fluorescence co-localization imaging, proteomics, CRISPR knockout, and organelle quality-control assays are commonly used [1,4,7].
Can CRISPR knockout help study GO:0072663?
Yes, CRISPR knockout models can test whether a gene is required for peroxisomal protein localization.
What is the difference between peroxisomal and mitochondrial protein targeting?
Peroxisomal targeting uses folded-protein translocation machinery, whereas mitochondrial targeting typically involves unfolded-protein import pathways.
How does organelle quality control relate to peroxisomal protein localization?
Mitophagy and mitochondrial quality-control pathways intersect with peroxisomal biology through shared stress responses and organelle crosstalk [1,2,6].
What cell models are available for peroxisomal protein localization research?
Knockout, point-mutation, knock-in, tagged knock-in, and overexpression models can be generated with CRISPR technologies [4,7].
Conclusion
GO:0072663 establishment of protein localization to peroxisome is a fundamental biological process that ensures peroxisomes receive the proteins required for their metabolic and quality-control functions. Understanding its mechanisms, genes, and regulation provides insight into organelle biology and disease-associated pathways, including cancer cell survival and metabolic stress [1,6]. CRISPR-based models and imaging approaches offer powerful tools to dissect this process and to identify new therapeutic targets [4,7].
References
- 1. Praharaj PP et al.. 2024. CLU (clusterin) and PPARGC1A/PGC1α coordinately control mitophagy and mitochondrial biogenesis for oral cancer cell survival.. Autophagy 20(6):1359-1382 PMID: 38447939
- 2. Song H et al.. 2021. CREG1 improves the capacity of the skeletal muscle response to exercise endurance via modulation of mitophagy.. Autophagy 17(12):4102-4118 PMID: 33726618
- 3. Jackson CL. 2019. Lipid droplet biogenesis.. Curr Opin Cell Biol 59:88-96 PMID: 31075519
- 4. Nelson BK et al.. 2007. A multicolored set of in vivo organelle markers for co-localization studies in Arabidopsis and other plants.. Plant J 51(6):1126-36 PMID: 17666025
- 5. Gu WJ et al.. 2022. [Effect of electroacupuncture invention on activities of PGC-1α/Irisin (FNDC5)/BDNF signaling in cerebral cortex, hippocampus and muscles in focal cerebral ischemic/reperfusion injury rats].. Zhen Ci Yan Jiu 47(5):428-34 PMID: 35616417
- 6. Shi Y et al.. 2025. GSTK1 suppresses HCC aggravation via L-carnitine metabolism by PGAM5/DRP1 complex-mediated mitochondrial quality control.. J Exp Clin Cancer Res 45(1):1 PMID: 41276823
- 7. Pei D et al.. 2022. Membrane translocation of folded proteins.. J Biol Chem 298(7):102107 PMID: 35671825
- 8. Hu Y et al.. 2026. PLA2G2F suppresses ferroptosis through phospholipid remodeling.. Nat Struct Mol Biol 33(8):1147-1157 PMID: 42486993
